In This Article:
-
Consolidated Gross Profit (Q4 2024): $21.6 million, flat compared to Q4 2023.
-
Consolidated Gross Profit (Fiscal 2024): $79.8 million, up from $76.7 million in Fiscal 2023.
-
Adjusted EBITDA (Q4 2024): $6.3 million, down from $8.9 million in Q4 2023.
-
Adjusted EBITDA (Fiscal 2024): $25.9 million, compared to $26.6 million in Fiscal 2023.
-
Adjusted EPS (Fiscal 2024): $2.03, compared to $2.04 in Fiscal 2023.
-
Engineering Gross Profit (Q4 2024): $5.2 million, down from $6.1 million in Q4 2023.
-
Engineering Gross Margin (Q4 2024): 19.7%, compared to 27.0% in Q4 2023.
-
IT, Life Sciences, and Data Solutions Gross Profit (Q4 2024): $3.9 million, down from $4.5 million in Q4 2023.
-
IT, Life Sciences, and Data Solutions Gross Margin (Q4 2024): 40.0%, up from 38.7% in Q4 2023.
-
Healthcare Gross Profit (Q4 2024): $12.5 million, up from $11.0 million in Q4 2023.
-
Healthcare Gross Margin (Q4 2024): 30.0%, compared to 29.8% in Q4 2023.
-
School Revenue (Q4 2024): $34.9 million, up from $29.8 million in Q4 2023.
-
Non-School Revenue (Q4 2024): $6.2 million, down from $6.9 million in Q4 2023.
-
Days Sales Outstanding (DSO) (Q4 2024): Reduced to 92 from 114 in Q3 2023.
Release Date: March 13, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
-
RCM Technologies Inc (NASDAQ:RCMT) demonstrated strong topline momentum with strategic initiatives gaining traction.
-
The company reported a resumption of growth in hours and increasing activity across most business units despite macroeconomic uncertainties.
-
RCM Healthcare closed 2024 on a high note with growth in hours and a robust pipeline of new school districts and clients.
-
The aerospace and defense group experienced significant growth, increasing headcount by 20% in 2024 and realizing a healthy increase in EBITDA.
-
RCM Technologies Inc (NASDAQ:RCMT) secured multi-year renewals for managed service engagements, demonstrating client loyalty and consistent quality delivery.
Negative Points
-
Profitability in Q4 was disappointing due to discrete items that materially impacted the quarter.
-
A significant industrial process equipment order was abruptly canceled, causing a reduction in gross profit.
-
The technical publications group experienced significant rework on a large project, impacting revenue and profit.
-
The company's self-insured medical plan had abnormally high costs, increasing SG&A expenses.
-
A class action lawsuit settlement regarding California wages added unexpected legal and settlement costs.